查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
注意力不足過動症的全球市場(2023年～2032年):市場佔有率，規模，趨勢，產業分析，各藥物類型，人口統計別，各流通管道，各地區，市場區隔預測
市場調查報告書
商品編碼
1191458

注意力不足過動症的全球市場(2023年～2032年):市場佔有率，規模，趨勢，產業分析，各藥物類型，人口統計別，各流通管道，各地區，市場區隔預測

Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, and Non-Stimulants); By Demographics; By Distribution Channel; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

全球注意力不足過動症的市場規模在2032年前將達到321億4,000萬美元。

本報告提供全球注意力不足過動症市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 關於報告
    • 調查目的
    • 市場範圍
    • 前提條件
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料資訊來源
    • 一級資訊來源
    • 二級資訊來源

第4章 全球注意力不足過動症市場:洞察

  • 產業的概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商者的威脅(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(高)
  • 大環境分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球注意力不足過動症市場:各藥物類型

  • 主要調查結果
  • 簡介
    • 各藥物類型的全球市場(2019年～2032年)
  • 刺激性
    • 刺激性別，各地區
    • 安非他命
    • ?醋甲酯
    • Lisdexamfetamine
    • ?醋甲酯
  • 非刺激性
    • 非刺激性別，各地區
    • 托莫西汀
    • 胍法辛
    • 可樂定
    • 其他

第6章 全球注意力不足過動症市場:各流通管道

  • 主要調查結果
  • 簡介
    • 各流通管道的全球市場(2019年～2032年)
  • 零售藥局
    • 零售藥局，各地區
  • 醫院藥局
    • 醫院藥局，各地區

第7章 全球注意力不足過動症市場:人口統計別

  • 主要調查結果
  • 簡介
    • 人口統計別的全球市場(2019年～2032年)
  • 兒童(2歲～17歲)
    • 兒童(2歲～17歲)，各地區
  • 大人
    • 大人，各地區

第8章 全球注意力不足過動症市場:各地區

  • 主要調查結果
  • 簡介
    • 注意力不足過動症市場評估:各地區(2019年～2032年)
  • 北美
    • 各藥物類型
    • 人口統計別
    • 各流通管道
    • 美國
    • 加拿大
  • 歐洲
    • 各藥物類型
    • 人口統計別
    • 各流通管道
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 各藥物類型
    • 人口統計別
    • 各流通管道
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東·非洲
    • 各藥物類型
    • 人口統計別
    • 各流通管道
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 各藥物類型
    • 人口統計別
    • 各流通管道
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭情形

  • 擴張和收購的分析
    • 擴張
    • 收購
  • 夥伴關係/合作/協定/展示會

第10章 企業簡介

  • Adlon Therapeutics L.P
  • Amnel Pharmaceuticals LLC
  • Aytu Biopharma, Inc
  • American Brivision(Holding)Corporation
  • Cingulate Inc
  • Eli Lilly And Company
  • GSK plc
  • Johnson & Johnson Services, Inc.
  • Neos Therapeutics, Inc
  • Novartis AG
  • Noven Pharmaceuticals, Inc
  • Otsuka Pharmaceutical Co., Ltd
  • Purdue Pharma L.P
  • RespireRx Pharmaceuticals Inc
  • Supernus Pharmaceuticals, Inc
  • Takeda Pharmaceutical Company Limited
  • Tris Pharma, Inc
Product Code: PM2960

The global attention deficit hyperactivity disorder market size is expected to reach USD 32.14 billion by 2032, according to a new study by Polaris Market Research. The report "Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, and Non-Stimulants); By Demographics; By Distribution Channel; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The expansion of the worldwide attention deficit hyperactivity disorder (ADHD) treatment market is anticipated to be fueled by prominent firms specializing in research & development for the treatment of the condition. For instance, in June 2020, Otsuka Pharmaceutical Co., Ltd. released the phase 3 clinical trials evaluating the effectiveness, safety, and tolerability of oral centanafadin for the treatment of adults with ADHD. Along with investigating centanafadine's effects in young children with ADHD, the business also intends to consult with the US Food and Drug Administration about the following procedures.

Furthermore, according to a study published in February 2021 and titled "The incidence of adult attention-deficit hyperactivity disorder: A global critical appraisal and meta-analysis," the pervasiveness of persistent adult ADHD was 2.6%, and the incidence of symptomatic adult ADHD was 6.7%, transforming to 139.8 Mn & 366.3 Mn affected adults worldwide, in 2020. The market is therefore likely to grow throughout the forecast period due to the growing burden of ADHD and the rising need for its treatment.

Additionally, medicine FDA approvals for attention deficit hyperactivity disorder are rising which is boosting the market growth over the forecast period. For instance, in July 2021, Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII's prescription information was updated owing to FDA approval of a supplementary New Drug Application (sNDA), according to a statement from the Adlon Therapeutics.

Also, the establishment of a center of excellence to enhance diagnosis, treatment, and care in Southeast Asia will be supported by a collaboration between Siemens Healthcare HMI Group, which was established in February 2022. This collaboration advances the study and creation of brand-new ADHD medications in the Asia Pacific area. The market for treatments for ADHD has been adversely affected by the Covid-19 outbreak. involving the industries. Due to the fast urbanization and growing need for efficient use of space that already exists, the sector anticipates a lot of needs and demands following the pandemic.

Attention Deficit Hyperactivity Disorder Market Report Highlights

The hospital pharmacy segment is anticipated to grow at a high CAGR over the forecast period. As drug specialists, hospital pharmacists can help ADHD patients and their parents choose the right medications.

The adult segment accounted for largest revenue share due to the huge target population base and increased risk of acquiring focus hyperactivity disorder.

Asia-Pacific is expected to grow at a high CAGR over the projected period. The existence of major market participants and their strategic efforts to create and promote innovative patient-focused goods

The global players include Adlon Therapeutics, American Brivision, Cingulate Inc., Eli Lilly, Neos Therapeutics, Novartis AG, Noven Pharmaceuticals, Purdue Pharma, RespireRx Pharmaceuticals, Supernus Pharmaceuticals, Takeda Pharmaceutical, and Tris Pharma.

Polaris Market Research has segmented the Attention Deficit Hyperactivity Disorder market report based on drug type, distribution channel, demographics, and region:

Attention Deficit Hyperactivity Disorder, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

Stimulants

Amphetamine

Methylphenidate

Lisdexamfetamine

Dexmethylphenidate

Non-stimulants

Atomoxetine

Guanfacine

Clonidine

Others

Attention Deficit Hyperactivity Disorder, Demographics Outlook (Revenue - USD Billion, 2019 - 2032)

Children (2 to 17 years of age)

Adults

Attention Deficit Hyperactivity Disorder, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Retail Pharmacy

Hospital Pharmacy

Attention Deficit Hyperactivity Disorder, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Attention Deficit Hyperactivity Disorder Market Insights

  • 4.1. Attention Deficit Hyperactivity Disorder - Industry Snapshot
  • 4.2. Attention Deficit Hyperactivity Disorder Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Awareness About ADHD Among Physicians and Patients
      • 4.2.1.2. Increasing Prevalence of ADHD
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Low Availability of Non-stimulant ADHD Drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Attention Deficit Hyperactivity Disorder Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3. Stimulants
    • 5.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Stimulants, by Region, 2019-2032 (USD Billion)
    • 5.3.2. Amphetamine
      • 5.3.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Amphetamine, by Region, 2019-2032 (USD Billion)
    • 5.3.3. Methylphenidate
      • 5.3.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Methylphenidate, by Region, 2019-2032 (USD Billion)
    • 5.3.4. Lisdexamfetamine
      • 5.3.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Lisdexamfetamine, by Region, 2019-2032 (USD Billion)
    • 5.3.5. Dexmethylphenidate
      • 5.3.5.1. Global Attention Deficit Hyperactivity Disorder Market, by Dexmethylphenidate, by Region, 2019-2032 (USD Billion)
  • 5.4. Non-stimulants
    • 5.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Non-stimulants, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Atomoxetine
      • 5.4.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Atomoxetine, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Guanfacine
      • 5.4.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Guanfacine, by Region, 2019-2032 (USD Billion)
    • 5.4.4. Clonidine
      • 5.4.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Clonidine, by Region, 2019-2032 (USD Billion)
    • 5.4.5. Other
      • 5.4.5.1. Global Attention Deficit Hyperactivity Disorder Market, by Other, by Region, 2019-2032 (USD Billion)

6. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacy
    • 6.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)

7. Global Attention Deficit Hyperactivity Disorder Market, by Demographics

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • 7.3. Children (2 to 17 years of age)
    • 7.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Children (2 to 17 years of age), by Region, 2019-2032 (USD Billion)
  • 7.4. Adults
    • 7.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Adults, by Region, 2019-2032 (USD Billion)

8. Global Attention Deficit Hyperactivity Disorder Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Attention Deficit Hyperactivity Disorder Market - North America
    • 8.3.1. North America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
    • 8.3.3. North America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Attention Deficit Hyperactivity Disorder Market - U.S.
      • 8.3.4.1. U.S.: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Attention Deficit Hyperactivity Disorder Market - Canada
      • 8.3.5.1. Canada: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Attention Deficit Hyperactivity Disorder Market - Europe
    • 8.4.1. Europe: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Attention Deficit Hyperactivity Disorder Market - UK
      • 8.4.4.1. UK: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Attention Deficit Hyperactivity Disorder Market - France
      • 8.4.5.1. France: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Attention Deficit Hyperactivity Disorder Market - Germany
      • 8.4.6.1. Germany: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Attention Deficit Hyperactivity Disorder Market - Italy
      • 8.4.7.1. Italy: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Attention Deficit Hyperactivity Disorder Market - Spain
      • 8.4.8.1. Spain: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Attention Deficit Hyperactivity Disorder Market - Netherlands
      • 8.4.9.1. Netherlands: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Attention Deficit Hyperactivity Disorder Market - Russia
      • 8.4.10.1. Russia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Attention Deficit Hyperactivity Disorder Market - Asia Pacific
    • 8.5.1. Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Attention Deficit Hyperactivity Disorder Market - China
      • 8.5.4.1. China: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Attention Deficit Hyperactivity Disorder Market - India
      • 8.5.5.1. India: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Attention Deficit Hyperactivity Disorder Market - Malaysia
      • 8.5.6.1. Malaysia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Attention Deficit Hyperactivity Disorder Market - Japan
      • 8.5.7.1. Japan: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Attention Deficit Hyperactivity Disorder Market - Indonesia
      • 8.5.8.1. Indonesia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Attention Deficit Hyperactivity Disorder Market - South Korea
      • 8.5.9.1. South Korea: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Attention Deficit Hyperactivity Disorder Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Attention Deficit Hyperactivity Disorder Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Attention Deficit Hyperactivity Disorder Market - UAE
      • 8.6.5.1. UAE: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Attention Deficit Hyperactivity Disorder Market - Israel
      • 8.6.6.1. Israel: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Attention Deficit Hyperactivity Disorder Market - South Africa
      • 8.6.7.1. South Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Attention Deficit Hyperactivity Disorder Market - Latin America
    • 8.7.1. Latin America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Attention Deficit Hyperactivity Disorder Market - Mexico
      • 8.7.4.1. Mexico: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Attention Deficit Hyperactivity Disorder Market - Brazil
      • 8.7.5.1. Brazil: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Attention Deficit Hyperactivity Disorder Market - Argentina
      • 8.7.6.1. Argentina: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Adlon Therapeutics L.P
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amnel Pharmaceuticals LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Aytu Biopharma, Inc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. American Brivision (Holding) Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Cingulate Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Eli Lilly And Company
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GSK plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson Services, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Neos Therapeutics, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Noven Pharmaceuticals, Inc
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Otsuka Pharmaceutical Co., Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Purdue Pharma L.P
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. RespireRx Pharmaceuticals Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Supernus Pharmaceuticals, Inc
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Takeda Pharmaceutical Company Limited
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Tris Pharma, Inc
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development

List of Tables

  • Table 1 Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 2 Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 4 Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 6 North America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 8 U.S.: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 11 Canada: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 14 Europe: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 17 UK: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 UK: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 20 France: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 21 France: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 23 Germany: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 26 Italy: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 29 Spain: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 35 Russia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 41 China: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 42 China: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 44 India: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 45 India: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 50 Japan: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 56 South Korea: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 65 UAE: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 68 Israel: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 71 South Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 74 Latin America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 77 Mexico: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 80 Brazil: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)
  • Table 83 Argentina: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Attention Deficit Hyperactivity Disorder Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Demographics
  • Figure 11. Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2021 & 2030 (USD Billion)
  • Figure 12. Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Attention Deficit Hyperactivity Disorder Market